Table 1.

Sociodemographic characteristics of the patients’ sample

	Total (N = 2,059)		Males (N = 1,210)		Females (N = 849)
	N	%	N	%	N	%
Age Mean (SD) in years	62.4	(14.2)	64.8	(11.9)	59.1	(16.4)
Age category
18-35 y.	141	6.8	53	4.4	88	10.4
36-45 y.	138	6.7	30	2.5	108	12.7
46-55 y.	233	11.3	108	8.9	125	14.7
56-65 y.	498	24.2	333	27.5	165	19.4
66-75 y.	788	38.3	544	45.0	244	28.7
76-94 y.	261	12.7	142	11.7	119	14.0
Diagnosis
Prostate	640	31.1	640	52.9	0	0.0
Breast	346	16.8	3	0.2	343	40.4
Colon	196	9.5	91	7.5	105	12.4
Kidney	119	5.8	68	5.6	51	6.0
Bladder	91	4.4	71	5.9	20	2.4
Rectum	90	4.4	56	4.6	34	4.0
Hodgkin lymphoma	64	3.1	28	2.3	36	4.2
Stomach	53	2.6	35	2.9	18	2.1
Ovary	41	2.0	0	0.0	41	4.8
Testis	35	1.7	35	2.9	0	0.0
Other non-Hodgkin lymphoma	31	1.5	17	1.4	14	1.6
Pancreas	31	1.5	21	1.7	10	1.2
Oesophagus	30	1.5	26	2.1	4	0.5
Non-follicular lymphoma	30	1.5	16	1.3	14	1.6
Thyroid gland	29	1.4	8	0.7	21	2.5
Others	233	11.3	95	7.9	138	16.3
Number of tumors
1	1,851	89.9	1,084	89.6	767	90.3
≥2	208	10.1	126	10.4	82	9.7
Surgery
no	208	10.1	110	9.1	98	11.5
yes	1,851	89.9	1,100	90.9	751	88.5
Radiation
no	1,424	69.2	973	80.4	451	53.1
yes	635	30.8	237	19.6	398	46.9
Chemotherapy
no	1,326	64.4	908	75.0	418	49.2
yes	733	35.6	302	25.0	431	50.8
Endocrine therapy
no	1,782	86.5	1,142	94.4	640	75.4
yes	277	13.5	68	5.6	209	24.6
Antibody therapy
no	1,934	93.9	1,166	96.4	768	90.5
yes	125	6.1	44	3.6	81	9.5